Polypeptide Principle and Characteristics — How Amino Acid Sequences Lead to Elasticity Care

When you see the term 'polypeptide' on an ingredient list, it's easy to pass over it as just another ingredient name. However, once you realize that the word itself is a term describing structure, the way you read ingredient lists changes. Today, focusing on this structural principle, we'll look at why polypeptides are designed in this form and why they are placed alongside other ingredients.

Why do peptides get named differently based on 'length'?

Peptides are a general term for substances made of amino acids linked together like a chain. When this chain is short, consisting of just a few links, it is called an oligopeptide, and when it is longer, it is called a polypeptide. This naming difference reflects a difference in molecular chain length, and this length difference is the reason each peptide is given a slightly different role in cosmetic formulation design.

This structural difference shows up in the ingredient labeling names. For example, notations containing the word 'polypeptide,' such as rh-Polypeptide-1, and notations containing the word 'oligopeptide,' such as sh-Oligopeptide-1 and rh-Oligopeptide-2, indicate substances that inherently differ in chain length. Although grouped together under the same 'peptide family,' they structurally belong to different categories.

One point should be made clear here. Describing peptides as amino acid chains refers to the chemical category of the ingredient, not a claim of specific physiological activity. It is accurate to understand peptides used in cosmetics as an ingredient category included in formulation design with elasticity care as the goal.

Different chain lengths lead to different formulation designs

Structures with long chains, like polypeptides, can exhibit different physical properties than short structures, like oligopeptides. This is why, in cosmetic formulation design, rather than using polypeptides alone, it is common to combine several types of peptides with different chain lengths to bring their distinct characteristics together into a single formulation.

This combination approach is not accidental but arises from structural reasons. The fact that peptides of different chain lengths appear together on the ingredient list can be seen as reflecting the intention to combine their distinct structural characteristics to complete a single elasticity care design. In other words, understanding the 'principle' of polypeptides also means understanding why this ingredient is always listed alongside peptides of other chain lengths.

Why polypeptides alone do not complete a formulation design

Structurally, polypeptides belong to the larger category of amino acid chain molecules. Large molecules behave differently on the skin's surface compared to small molecules, which is why, rather than designing with polypeptides alone, formulations are generally composed together with barrier-forming lipid-type ingredients and moisture-retaining ingredients. This structural background is also related to why barrier lipid ingredients such as ceramide NP, cholesterol, and palmitic acid, and moisturizing ingredients such as panthenol, betaine, and trehalose, are listed alongside polypeptides.

In addition, some domestic cosmetics combine polypeptides with ingredients like adenosine, which the Ministry of Food and Drug Safety has officially recognized for wrinkle improvement functionality. In this case, adenosine can be described as helping with wrinkle improvement only within the reviewed functional scope, while polypeptides should be understood as a separate ingredient category that supports elasticity care design alongside it. Not lumping the two together under the same efficacy is the correct way to read a full ingredient list.

The order for checking polypeptide structure on a full ingredient list

To actually verify this principle, there is a sequence to follow. First, find the exact labeled name containing the word 'polypeptide' on the full ingredient list. Next, check whether peptide notations with different chain lengths, such as 'oligopeptide,' appear nearby. Finally, look at whether barrier lipid-type ingredients, moisturizing ingredients, and domestically notified functional ingredients are arranged together with these peptides.

If all three of these are confirmed together, it provides grounds to conclude that the product was designed for elasticity care by combining polypeptides with other ingredients according to structural principles. Conversely, if only a single polypeptide is listed alone, without other peptides of different chain lengths or lipid/moisturizing ingredients present, the completeness of that design deserves a second look.

The final step: which cream to finish with

Once you understand polypeptides through the structural principle of chain length, the natural next question becomes 'in an actual formulation, in what order is this structural principle reflected in absorption design?' ARZTIN Regenerative Cilt Cream combines rh-polypeptide-1, sh-oligopeptide-1, and rh-oligopeptide-2, which have different chain lengths, and arranges them alongside centella asiatica-derived ingredients, barrier lipid-type ingredients, and oil-based ingredients, completing its elasticity care design as a final-step cream. Checking the full ingredient list directly lets you gauge how this structural principle has actually been arranged.